IDEXX Laboratories, Inc. vs Merck & Company, Inc. — Stock Comparison
Q·Score Breakdown
7.5
Bullish
Overall
6.7
Neutral
Quality
Health
Growth
Valuation
Sentiment
IDXX
High-quality business with 66% return on equity and 25% profit margins.
MRK
Forward P/E of 11.5× is low relative to sector peers.
Analyst Consensus
BUY
Target $724.50 (+27.7%)
14 analysts
BUY
Target $129.74 (+15.7%)
27 analysts
Fundamentals
IDXX
MRK
43.3×
Trailing P/E
31.5×
34.6×
Forward P/E
11.5×
24.6%
Profit Margin
13.6%
61.8%
Gross Margin
76.6%
66.2%
ROE
—
14.3%
Revenue Growth
4.9%
17.9%
Earnings Growth
—
1.72
Beta
0.28
—
Price / Book
—
$45.2B
Market Cap
$277.0B
$465 – $770
52-Week Range
$73 – $125
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →